ClinicalTrials.Veeva

Menu

Clinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia

H

Hospital Infantil de Mexico Federico Gomez

Status

Completed

Conditions

Rehabilitation
Recovery of Function
Pneumonia Childhood

Treatments

Other: Control Group
Other: Respiratory Pediatric Physiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06174454
HIM2017-055 SSA1376

Details and patient eligibility

About

The accumulation of secretions in the bronchopulmonary air network promotes the detriment of respiratory functions generating hypoxia and causing a decrease in the cardiac output requiring the use of mechanical ventilation and hemodynamic support. It is intended to control the accumulation of secretions by means of Respiratory Pediatric Physiotherapy (RPP) and to evaluate its effectiveness counting on biological plausibility.

Full description

The OBJECTIVE of this research protocol is to evaluate the effectiveness of RPP compared to postural drainage plus compression to the muscle belly of the upper limbs, as an adjuvant treatment for children with pneumonia. It is expected that the clinical severity decreases by 1.5 in the Wang score (a modification of the Silverman score), with a standard deviation of 2.6 points and a decrease of two days in the hospital stay with a α 0.05 in a one-tail test, a P of 80% and a 95.5% confidence interval.

Enrollment

88 patients

Sex

All

Ages

1 to 7 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients from the Hospital Infantil de México Federico Góme with diagnosis of pneumonia (considering the diagnostic criteria of the WHO and the Guidelines for Nosocomial Pneumonia from the infectiology department.
  2. Patients aged 0 to 8 years old.
  3. A minimum HS of 72 hours.
  4. Having informed consent.
  5. Not having had previous RPP treatment.

Exclusion criteria

  1. Presenting a fever state for more than three days. Performing physiotherapy increases the body's peripheral temperature.
  2. Presenting an oxygen saturation below 80%.
  3. Requiring mechanical ventilation.
  4. Hemodynamic instability.
  5. Presenting systemic inflammatory response syndrome.
  6. Inotropic support.
  7. Anatomical variants in the thorax.
  8. Unstable thorax.
  9. Esophageal atresia.
  10. Pleural effusion, pneumothorax.
  11. Alterations that compromise respiratory centers and/or the phrenic nerve.
  12. Neuromuscular diseases that compromise respiratory mechanics.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

88 participants in 2 patient groups, including a placebo group

Inervention group
Experimental group
Description:
The intervention group will be subject to RPP. Techniques of slow expiration will be used and slow inspiration for the sweeping of secretions, during its expulsion forced expiratory techniques will be used (tracheal reflex). 10 sessions will be performed, one a day from Monday to Friday, with a duration of 10 to 15 minutes.
Treatment:
Other: Respiratory Pediatric Physiotherapy
Control Group
Placebo Comparator group
Description:
Will be subject to PD plus muscle belly compressions of the upper limbs for 10 sessions, one session a day from Monday to Friday, with a duration de 10 to 15 minutes per patient. Both groups will receive the usual treatment for pneumonia prescribed by their treating doctor.
Treatment:
Other: Control Group

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems